PsychoactiveMap

Mclean Hospital psychedelic research trials

Data as of 11 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.

Mclean Hospital is listed with 4 registered studies counted here, in Belmont, United States. By compound: 1 MDMA and 3 ketamine. By registry status: 1 not yet recruiting, 1 completed, 1 terminated and 1 status not reported. By phase: 2 phase 2 and 2 not reported. Reported start years run from 2014 (earliest) to 2026 (latest).

Institution name, city and country are copied from the research site linked to each registry record. A study counts once per institution, and a study tagged with more than one compound is counted under each compound.

Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.

At a glance

By compound

Compound hubStudies
MDMA1
Ketamine3

By registry status

StatusStudiesShare
Not yet recruiting125%
Completed125%
Terminated125%
Status not reported125%

By phase

PhaseStudiesShare
Phase 2250%
Not reported250%

Registered studies

All counted studies, newest start first. The order is not a ranking and says nothing about quality. Titles are quoted from the registry. Each ID links to its own ClinicalTrials.gov record, which has the eligibility criteria and contacts.

Title as registeredRegistry IDStatusPhaseStartCompound
MDMA-AT for PTSD in Young Adults With Childhood TraumaNCT07765693Not yet recruitingPhase 22026-10-31MDMA
Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant DepressionNCT04239963CompletedNot reported2020-08-17Ketamine
Open Study of the Neurobiological Effects of Intranasal Ketamine in Children and Adults With Bipolar DisorderNCT05209217Status not reportedNot reported2019-06-04Ketamine
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive DisorderNCT02234011TerminatedPhase 22014-09-01Ketamine

About this data

Compound tags come from automated matching of the registry search term and have not been checked record by record. Counts are of registered studies, not of people, results or approvals. A registry listing is not evidence of safety, benefit or results.

Substance hubs for these compounds

MDMA | Ketamine

All trial hubs | Learn | Disclaimer